Xtl Biopharmaceuticals (XTLB) Share-based Compensation (IS) (2013 - 2016)
Xtl Biopharmaceuticals' Share-based Compensation (IS) came in at $37,000 for the year ended Dec 31, 2021, down 27.5% from $51,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Share-based Compensation (IS) (2013 - 2016) Analysis & Trends
Going back to the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Share-based Compensation (IS) data covers 13 years.
- Share-based Compensation (IS) carries a five-year compound annual growth rate of -27.3% (years ended Dec 2016 to Dec 2021).
- The five-year range for annual Share-based Compensation (IS) is $5,000 (the year ended Dec 31, 2019) to $51,000 (the year ended Dec 31, 2020).
- Per Business Quant, earlier years put Share-based Compensation (IS) at $51,000 in the year ended Dec 31, 2020 (+920.0%), $5,000 in the year ended Dec 31, 2019 (-79.2%), $24,000 in the year ended Dec 31, 2018 (-40.0%) and $40,000 in the year ended Dec 31, 2017 (-78.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 86,000.00 |
| Dec 31, 2015 | 29,000.00 |
| Sep 30, 2015 | 36,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Dec 31, 2014 | 28,000.00 |
| Sep 30, 2014 | 48,000.00 |
| Jun 30, 2014 | 65,000.00 |
| Mar 31, 2014 | 137,000.00 |
| Dec 31, 2013 | -555,000.00 |
| Sep 30, 2013 | -345,000.00 |
| Jun 30, 2013 | 389,000.00 |
| Mar 31, 2013 | 446,000.00 |
API Access
Xtl Biopharmaceuticals Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();